LPL Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
|
|||||
|
2025
Q1 | $4.54M | Buy |
|
|||||
|
2024
Q4 | $2.06M | Sell |
|
|||||
|
2024
Q3 | $2.32M | Buy |
|
|||||
|
2024
Q2 | $2.59M | Sell |
|
|||||
|
2024
Q1 | $2.84M | Buy |
|
|||||
|
2023
Q4 | $3.01M | Buy |
|
|||||
|
2023
Q3 | $2.72M | Buy |
|
|||||
|
2023
Q2 | $2.32M | Buy |
|
|||||
|
2023
Q1 | $2.47M | Sell |
|
|||||
|
2022
Q4 | $2.66M | Sell |
|
|||||
|
2022
Q3 | $2.25M | Sell |
|
|||||
|
2022
Q2 | $2.46M | Sell |
|
|||||
|
2022
Q1 | $2.47M | Sell |
|
|||||
|
2021
Q4 | $5.88M | Sell |
|
|||||
|
2021
Q3 | $5.57M | Buy |
|
|||||
|
2021
Q2 | $5.4M | Sell |
|
|||||
|
2021
Q1 | $5.49M | Buy |
|
|||||
|
2020
Q4 | $5.79M | Buy |
|
|||||
|
2020
Q3 | $3.65M | Buy |
|
|||||
|
2020
Q2 | $5.91M | Buy |
|
|||||
|
2020
Q1 | $3.71M | Buy |
|
|||||
|
2019
Q4 | $3.28M | Sell |
|
|||||
|
2019
Q3 | $2.7M | Sell |
|
|||||
|
2019
Q2 | $3.68M | Buy |
|
|||||
|
2019
Q1 | $3.06M | Buy |
|
|||||
|
2018
Q4 | $2.56M | Buy |
|
|||||
|
2018
Q3 | $2.79M | Sell |
|
|||||
|
2018
Q2 | $2.78M | Buy |
|
|||||
|
2018
Q1 | $789K | Sell |
|
|||||
|
2017
Q4 | $1.1M | Sell |
|
|||||
|
2017
Q3 | $1.27M | Buy |
|
|||||
|
2017
Q2 | $1.22M | Buy |
|
|||||
|
2017
Q1 | $291K | Buy |
|
|||||
|
2016
Q4 | $218K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $518K | Sell |
|
|||||
|
2015
Q4 | $901K | Buy |
|
|||||
|
2015
Q3 | $641K | Buy |
|
|||||
|
2015
Q2 | $727K | Buy |
|
|||||
|
2015
Q1 | $475K | Buy |
|
|||||
|
2014
Q4 | $214K | Sell |
|
|||||
|
2014
Q3 | $268K | Sell |
|
|||||
|
2014
Q2 | $774K | Sell |
|
|||||
|
2014
Q1 | $1.07M | Buy |
|
|||||
|
2013
Q4 | $872K | Buy |
|
|||||
|
2013
Q3 | $473K | Buy |
|